Winning studies were chosen by members of the Clinical Research Forum, a nonprofit foundation that promotes the understanding of clinical research and its impact on health and health care.
Three research teams led by Stanford Medicine investigators will be honored April 14 with a 2020 Top 10 Clinical Research Achievement Award at a ceremony in Washington, D.C.
The awards honor groundbreaking clinical research studies published in peer-reviewed journals in 2019. Stanford’s three award-winning papers are:
- Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomized, double-blind, placebo-controlled, phase 2 study, published in The Lancet. The author representing the team is Rebecca Sharon Chinthrajah, MD, clinical associate professor of medicine and of pediatrics.
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy, published in The New England Journal of Medicine. The author representing the team is Kenneth Mahaffey, MD, professor of cardiovascular medicine.
- Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation, published in The New England Journal of Medicine. The author representing the team is Marco Perez, MD, associate professor of cardiovascular medicine.
Winning studies were chosen by members of the Clinical Research Forum, a nonprofit foundation that promotes the understanding of clinical research and its impact on health and health care.
Studies were selected based on their degree of innovation and novelty; contribution to the understanding of human disease or physiology, or both; and potential impact upon the diagnosis, prevention and/or treatment of disease.
At the ceremony, which takes place during the Clinical Research Forum’s Annual Meeting, one of the 10 studies will receive the Herb Pardes Clinical Research Excellence Award, which includes a prize of $7,500. Two runner-up studies will receive the Distinguished Clinical Research Achievement Award, which includes a prize of $5,000 each. On the following day, one representative from each team will participate in meetings with congressional offices to promote the importance of funding for clinical research.